Page 142 - 《中国药房》2025年20期

plays a role in the beneficial effects of semaglutide（GLP- [28] BEIROA D，IMBERNON M，GALLEGO R，et al. GLP-1
1 receptor agonist）on the liver of obese mice[J]. Clin Res agonism stimulates brown adipose tissue thermogenesis
Hepatol Gastroenterol，2022，46（6）：101922. and browning through hypothalamic AMPK[J]. Diabetes，
[18] PERFIELD J W，2nd，ORTINAU L C，PICKERING R T， 2014，63（10）：3346-3358.
et al. Altered hepatic lipid metabolism contributes to non‐ [29] LOCKIE S H，HEPPNER K M，CHAUDHARY N，et al.
alcoholic fatty liver disease in leptin-deficient ob/ob mice Direct control of brown adipose tissue thermogenesis by
[J]. J Obes，2013，2013：296537. central nervous system glucagon-like peptide-1 receptor
[19] SOTO-CATALÁN M，OPAZO-RÍOS L，QUICENO H，et signaling[J]. Diabetes，2012，61（11）：2753-2762.
al. Semaglutide improves liver steatosis and de novo lipo‐ [30] ZHAO L，CHEN Y，XIA F Z，et al. A glucagon-like pep‐
genesis markers in obese and type-2-diabetic mice with tide-1 receptor agonist lowers weight by modulating the
metabolic-dysfunction-associated steatotic liver disease structure of gut microbiota[J]. Front Endocrinol （Lausanne），
[J]. Int J Mol Sci，2024，25（5）：2961. 2018，9：233.
[20] VENDRELL J，EL BEKAY R，PERAL B，et al. Study of [31] DENG X L，MA J，SONG M T，et al. Effects of products
the potential association of adipose tissue GLP-1 receptor designed to modulate the gut microbiota on hyperlipidae‐
with obesity and insulin resistance[J]. Endocrinology， mia[J]. Eur J Nutr，2019，58（7）：2713-2729.
2011，152（11）：4072-4079. [32] ZENG Y，WU Y F，ZHANG Q，et al. Crosstalk between
glucagon-like peptide 1 and gut microbiota in metabolic
[21] CHEN J C，ZHAO H C，MA X L，et al. GLP-1/GLP-1R
diseases[J]. mBio，2024，15（1）：e0203223.
signaling in regulation of adipocyte differentiation and li‐
[33] ZHAO L，QIU Y，ZHANG P P，et al. Gut microbiota me‐
pogenesis[J]. Cell Physiol Biochem，2017，42（3）：1165-
diates positive effects of liraglutide on dyslipidemia in
1176.
mice fed a high-fat diet[J]. Front Nutr，2022，9：1048693.
[22] LI Y M，DU J Y，ZHU E D，et al. Liraglutide suppresses
[34] MAO T H，ZHANG C X，YANG S，et al. Semaglutide al‐
proliferation and induces adipogenic differentiation of
ters gut microbiota and improves NAFLD in db/db mice
3T3-L1 cells via the Hippo-YAP signaling pathway[J].
[J]. Biochem Biophys Res Commun，2024，710：149882.
Mol Med Rep，2018，17（3）：4499-4507.
[35] RODBARD H W，LINGVAY I，REED J，et al. Semaglu‐
[23] ZHANG J M，YANG G C，LIU J B，et al. Glucagon-like
tide added to basal insulin in type 2 diabetes（SUSTAIN
peptide-1 analog liraglutide reduces fat deposition in
5）：a randomized，controlled trial[J]. J Clin Endocrinol
chicken adipocytes[J]. Poult Sci，2024，103（7）：103766.
Metab，2018，103（6）：2291-2301.
[24] ZHU R Y，CHEN S C. Proteomic analysis reveals sema-
[36] DAHL K，BROOKS A，ALMAZEDI F，et al. Oral sema-
glutide impacts lipogenic protein expression in epididymal
glutide improves postprandial glucose and lipid metabo‐
adipose tissue of obese mice[J]. Front Endocrinol
lism，and delays gastric emptying，in subjects with type 2
（Lausanne），2023，14：1095432.
diabetes[J]. Diabetes Obes Metab，2021，23（7）：1594-
[25] LI H，LIU G，WAN X Q，et al. The zinc finger and BTB
1603.
domain containing protein ZBTB20 regulates plasma tri-
[37] LOOMBA R，ABDELMALEK M F，ARMSTRONG M J，
glyceride metabolism by repressing lipoprotein lipase
et al. Semaglutide 2.4 mg once weekly in patients with
gene transcription in hepatocytes[J]. Hepatology，2022，75
non-alcoholic steatohepatitis-related cirrhosis： a ran‐
（5）：1169-1180. domised，placebo-controlled phase 2 trial[J]. Lancet Gas‐
[26] LI Y，GAO R，YANG Z Y，et al. Liraglutide modulates troenterol Hepatol，2023，8（6）：511-522.
lipid metabolism via ZBTB20-LPL pathway[J]. Life Sci， [38] SVANE M S，JOHANNESEN H H，HANSEN A E，et al.
2025，360：123267. Four weeks treatment with the GLP-1 receptor analogue li‐
[27] NOGUEIRAS R，PÉREZ-TILVE D，VEYRAT-DUREBEX raglutide lowers liver fat and concomitantly circulating
C，et al. Direct control of peripheral lipid deposition by glucagon in individuals with overweight[J]. Int J Obes
CNS GLP-1 receptor signaling is mediated by the sympa‐ （Lond），2022，46（11）：2058-2062.
thetic nervous system and blunted in diet-induced obesity （收稿日期：2025-05-08 修回日期：2025-09-22）
[J]. J Neurosci，2009，29（18）：5916-5925. （编辑：邹丽娟）

· 2620 · China Pharmacy 2025 Vol. 36 No. 20 中国药房 2025年第36卷第20期